Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.36 | N/A |
| PEG Ratio (TTM) | -3.06 | N/A |
| P/S Ratio (TTM) | 2.49 | N/A |
| P/B Ratio (TTM) | 4.34 | N/A |
| P/FCF Ratio (TTM) | 15.32 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.77 | N/A |
| Price to 5YR AVG FCF Ratio | 14.22 | N/A |
Profitability (85%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 16.19% | N/A |
| ROE (TTM) | 25.67% | N/A |
| Net Profit Margin (TTM) | 14.29% | N/A |
| ROIC 5YR AVG | 61.98% | N/A |
Growth (87%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 9.76% | 1,915.89% | 1,130.45% |
| Revenue | 0.39% | 21.89% | 3.46% |
| Net Income | 9.36% | 1,721.14% | 1,011.74% |
| Cash Flow | 9.82% | 123.60% | 55.10% |
Health (89%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.92 | N/A |
| Quick Ratio (TTM) | 1.69 | N/A |
| D/E Ratio (TTM) | 0.21 | N/A |
| Interest Coverage (TTM) | 33.81 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 7.77 | N/A |
| LTL to 5YR AVG FCF | 0.73 | N/A |
| Shares Outstanding Growth 5YR AVG | -12.73% | N/A |